The global creatine kinase reagent market was valued at around USD 296.2 Million at the end of 2021. The market is projected to register a 10.5% CAGR and top a valuation of USD 803.9 Million by 2032.
Increasing prevalence of cardiovascular disorders among the population and the utilization of the reagents across the healthcare industry across the globe is expected to propel the creatine kinase reagent market growth.
Creatine kinase is a cardiac biomarker that alludes to the substances that are released in the bloodstream, owing to heart injury or stress, majorly caused by inadequate blood flow. The quantification of creatine kinase is used for the analysis of various heart situations, such as acute coronary syndrome, acute myocardial infarction, congestive heart failure, ischemia, and others.
| Attributes | Details |
|---|---|
| Creatine Kinase Reagent Market Value in 2021 | USD 296.2 Million |
| Creatine Kinase Reagent Market Value in 2032 | USD 803.9 Million |
| Creatine Kinase Reagent Market CAGR (2022 to 2032) | 10.50% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The increasing prevalence of cardiovascular disorders among the populace is the major factor propelling the growth of the creatine kinase reagent market. Cardiovascular diseases are one of the major causes of demise, because of the changing and unhealthy lifestyle. Thus, this leads to an increase in the number of patients suffering from cardiovascular disorders and is expected to drive the growth rate of the market in the upcoming years.
Furthermore, the advancements in technology are new opportunities for research and development applications. The budding demand for cardiac testing kits, advanced development of creatine kinase reagents, and the sensitivity and high specificity of the creatine kinase reagents-based tests for accurate and efficient analysis are the aspects that are expected to fuel the market growth during the forecast period.
Moreover, factors such as the increasing geriatric population base, the growing prevalence of an unhealthy lifestyle among people, and unhealthy food and drink consumption, lead to obesity and are the attributes to the rising prevalence of target diseases. This demands the high requirements of ligases that are anticipated to be the major factors driving the market growth.
North America holds the largest share in the global creatine kinase reagent market owing to the well-established pharmaceutical companies, research institutes, and laboratories in this region. Additionally, the increasing scope of research and development activities in the countries like the USA is expected to accelerate the market during the projected period.
Besides North America, Europe and Asia Pacific regions are also expected to show lucrative growth over the forecast period. The increase in the population suffering from acute myocardial infarction, acute coronary syndrome, and other cardiac disorders is the major factor that is expected to fuel the market growth in Asia Pacific Region.
Principal Consultant
Some of the key manufacturers operating in the creatine kinase reagent market are BBI Solutions, Abbott, Beckman Coulter, Inc., Boditech Med Inc., DiaSys Diagnostic Systems GmbH, Fujirebio, Novus Biologicals, LLC., PerkinElmer Inc., Pointe Scientific Inc., Randox Laboratories Ltd., and Thermo Fisher Scientific.
| Report Attributes | Details |
|---|---|
| Growth Rate | CAGR of 10.5% 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2012 to 2021 |
| Forecast Period | 2022 to 2032 |
| Qualitative Units | Revenue in USD Billion, Volume in Kilotons, and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segment Covered | Product, Type, Application, End User, Region |
| Region Covered | North America; Latin America; Europe; East Asia; South Asia; Oceania; Middle East Africa |
| Key Countries Profiled | USA, Canada, Brazil, Mexico, Germany, UK, France, Spain, Italy, China, Japan, South Korea, Malaysia, Singapore, Australia, New Zealand, GCC, South Africa, Israel |
| Key Players | BBI Solutions; Abbott; Beckman Coulter, Inc.; Boditech Med Inc.; DiaSys Diagnostic Systems GmbH; Fujirebio; Novus Biologicals, LLC; PerkinElmer Inc.; Pointe Scientific Inc.; Randox Laboratories Ltd.; Thermo Fisher Scientific |
| Customization | Available Upon Request |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The global creatine kinase reagent market is anticipated to register a CAGR of 10.5% during the forecast period.
BBI Solutions, Abbott, Beckman Coulter Inc., Boditech Med Inc.., DiaSys Diagnostic Systems GmbH, Fujirebio, Novus Biologicals, PerkinElmer, and Pointe Scientific Inc., among others are some prominent creatine kinase reagent market players.
1. Executive Summary 2. Industry Introduction, including Taxonomy and Market Definition 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections 5. Pricing Analysis 6. Global Market Analysis and Forecast 6.1. Product 6.2. Type 6.3. Application 6.4. End User 7. Global Market Analysis and Forecast, By Product 7.1. Creatine Kinase Reagents 7.2. Creatine Kinase Instruments 7.3. Creatine Kinase Kits 8. Global Market Analysis and Forecast, By Type 8.1. Colorimetric Assay Based Creatine Kinase Tests 8.2. Enzymatic Creatine Kinase Tests 8.3. Point of Care Creatine Kinase Tests 8.4. ELISA-based Creatine Kinase Tests 8.5. Other Creatine Kinase Test Types 9. Global Market Analysis and Forecast, By Application 9.1. Creatine Kinase Reagents for Research Use 9.2. Creatine Kinase Reagents for Diagnosis Use 10. Global Market Analysis and Forecast, By End User 10.1. Creatine Kinase Reagents for Hospitals 10.2. Creatine Kinase Reagents for Clinics 10.3. Creatine Kinase Reagents for Diagnostic Laboratories 10.4. Creatine Kinase Reagents for Academic Research Institutes 10.5. Creatine Kinase Reagents for Other End Users 11. Global Market Analysis and Forecast, By Region 11.1. North America 11.2. Latin America 11.3. Europe 11.4. East Asia 11.5. South Asia & Pacific 11.6. The Middle East and Africa (MEA) 12. North America Sales Analysis and Forecast, by Key Segments and Countries 13. Latin America Sales Analysis and Forecast, by Key Segments and Countries 14. Europe Sales Analysis and Forecast, by Key Segments and Countries 15. East Asia Sales Analysis and Forecast, by Key Segments and Countries 16. South Asia & Pacific Sales Analysis and Forecast, by Key Segments and Countries 17. The Middle East and Africa (MEA) Sales Analysis and Forecast, by Key Segments and Countries 18. Sales Forecast by Product, Type, Application, and End User for 30 Countries 19. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 20. Company Profile 20.1. Abbott 20.2. Beckman Coulter Inc. 20.3. Boditech Med Inc. 20.4. DiaSys Diagnostic Systems GmbH 20.5. Fujirebio 20.6. Novus Biologicals LLC 20.7. PerkinElmer Inc. 20.8. Pointe Scientific Inc. 20.9. Randox Laboratories Ltd. 20.10. Thermo Fisher Scientific 20.11. Abbott
Explore Healthcare Insights
View Reports
Creatine Kinase Reagent Market
